Evidence map›Paper›PMID 33308975›Full record

Trial reportUrologic oncology2021

Financial incentives and wearable activity monitors to increase ambulation after cystectomy: A randomized controlled trial.

Marshall Strother, Kristen Koepsell, Lihai Song, Jennifer Faerber, Joshua Bernard, S Bruce Malkowicz, Thomas Guzzo, Gregory Tasian

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Urologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marshall StrotherDivision of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address: m12912988@gmail.com.
Kristen KoepsellDivision of Urology, Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, PA.
Lihai SongDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA.
Jennifer FaerberDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA.
Joshua BernardDivision of Urology, Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, PA.
S Bruce MalkowiczDivision of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Thomas GuzzoDivision of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Gregory TasianDivision of Urology, Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, PA; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USFox Chase Cancer Center · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
NCATS NIH HHS UL1 TR000003
6 · The paper itself

Abstract

objectivesFinancial incentive programs are effective in increasing physical activity for overweight, ambulatory adults. We sought to determine the potential effect size and direction of financial incentives on ambulation after radical cystectomy. MATERIALS AND

methodsWe performed a pilot randomized controlled trial of daily financial incentives to meet postoperative step goals among adults with Eastern Cooperative Oncology Group performance status ≤2 who underwent radical cystectomy for bladder cancer at a single center. Step counts were measured over a 3- to 14-day preoperative period and 30-day postoperative period using a wearable activity monitor. Postoperative daily step goals of 10%, 25%, 40%, and 55% of mean preoperative daily step counts were set for postoperative weeks 1 through 4, respectively. The primary outcome was the number of postoperative days on which the step goals were met. Secondary outcomes included the number of daily postoperative steps taken and the length of stay. Participants randomized to the intervention arm received $1.50 for every day the goal was met with a 20% chance of a $100 reward if the step goal was met on >75% of the first 30 postoperative days. Questionnaires assessing self-reported physical activity, disability, and social support were administered preoperatively at 30 days postoperatively.

resultsThirty-three patients were analyzed, 11 in the control and 22 in the intervention arms. There were no statistically significant differences between incentive and control arms for the primary outcome (4.5/30 days vs. 9/30 days, P = 0.53). Results after adjusting for differences in baseline characteristics were similar (RR 1.00, 95% CI 0.24-4.19, P = 1.00). There were also no differences in average daily postoperative steps (median 979 vs. 1191, 95% CI -810 to 1,400, P = 0.59), length of stay (7.5 vs. 7, 95% CI -2.7 to 5.1, P = 0.56), or self-reported measures of disability, activity, and social support.

conclusionsWhile this trial was a pilot study and not powered to detect a difference between groups, there was no suggestion of any clinically important impact of this financial incentive on postoperative ambulation. While a fully-powered trial is feasible, given the small range of plausible benefit, such a trial would be unlikely to influence clinical practice.

Indexed as

CystectomyExerciseMotivationPatient ComplianceWalkingAgedFemaleHumansMaleMiddle AgedMonitoring, PhysiologicUrinary Bladder NeoplasmsWearable Electronic DevicesBehavioral economicsFinancial incentiveRadical cystectomyUrothelial carcinoma

Identifiers

PMID33308975
PMCPMC8184881
OpenAlexW3111568307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.